Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):64–71. doi: 10.1097/QAI.0000000000001569

Table 1.

Prevalence of past-year and lifetime experiences of physical and/or sexual IPV for female PHIV youth, by sociodemographic and health characteristics

N (%) Past-Year
IPV
Lifetime
IPV
Sociodemographics
  Age group
    Mid-adolescence (13–16) 74 (57%) 16% 28%
    Late-adolescent (17–19) 33 (26%) 15% 36%
    Youth (20–24) 22 (17%) 32% 41%
  Caregiver
    Parent 71 (55%) 17% 28%
    Other 58 (45%) 21% 38%
  Wealth
    Bottom two quintiles 57 (44%) 18% 26%
    Top three quintiles 63 (66%) 17% 37%
Adverse childhood experiences
  0–3 adversities 12 (9%) 8% 8%
  4–7 adversities 45 (35%) 11% 20%
  8–13 adversities 72 (56%) 25% 44%
Health
  High risk sex in past year
    Yes 21 (16%) 52% 71%
    No 101 (84%) 12% 25%
  Ever pregnant
    Yes 13 (10%) 54% 100%
    No 114 (90%) 14% 25%
  Adherenceǂ
    Poor 39 (46%) 31% 38%
    Adequate 42 (54%) 7% 21%
  Viral load
    <200 76 (59%) 16% 34%
    >200 53 (41%) 23% 30%
  HIV status disclosure to boyfriend/girlfriend
    Yes 20 (16%) 20% 40%
    No 109 (84%) 18% 31%
  Depression
    Severe/moderate symptoms 48 (37%) 33% 50%
    Mild/no symptoms 76 (63%) 11% 21%
  Alcohol and drug use problems
    Yes 19 (15%) 42% 58%
    No 110 (85%) 15% 28%

Total Sample 129 (100%) 19% 33%
ǂ

measured among 85 participants reporting current ART use